BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7471522)

  • 1. Effect of depletion of spinal noradrenaline by 6-hydroxydopamine on the development of renal hypertension in rats.
    Bosland MC; Versteeg DH; van Put J; de Jong W
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):67-77. PubMed ID: 7471522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 6-hydroxydopamine and the PNMT inhibitor LY134046 on pressor responses to stimulation of the subretrofacial nucleus in anaesthetized stroke-prone spontaneously hypertensive rats.
    Head GA; Howe PR
    J Auton Nerv Syst; 1987 Mar; 18(3):213-24. PubMed ID: 3106455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain noradrenaline and the development of hypertension: the effect of treatment with central 6-hydroxydopamine or DSP-4.
    van den Buuse M; Versteeq DH; de Jong W
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):469-76. PubMed ID: 3093124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hypothalamic noradrenaline depletion with 6-hydroxydopamine on the body temperature regulation of the rat.
    Lin MT; Shian LR; Leu SY
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):131-5. PubMed ID: 6425702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal intraspinal 6-hydroxydopamine: depletion of norepinephrine but not dopamine.
    Ings R; Pappas B
    Eur J Pharmacol; 1981 Apr; 70(4):577-83. PubMed ID: 6263641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting peripheral and central effects of 6-hydroxydopamine in rats.
    Clark DW; Laverty R; Phelan EL
    Br J Pharmacol; 1972 Feb; 44(2):233-43. PubMed ID: 4677508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of intracisternal 6-hydroxydopamine and of subsequent lesions of the ventrolateral medulla coinciding with the Al group of noradrenaline cells in the rabbit.
    Elliott JM; Stead BH; West MJ; Chalmers J
    J Auton Nerv Syst; 1985; 12(2-3):117-30. PubMed ID: 3923089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of renal hypertensive rats.
    Kubo T; Hashimoto M; Ohashi T
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):270-8. PubMed ID: 708153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible role for spinal noradrenaline in the mechanisms of 6-hydroxydopamine against pentylenetetrazol induced convulsions in rats.
    Abed WT
    Life Sci; 1988; 43(22):1831-6. PubMed ID: 3143878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressor responsiveness of the sub-retrofacial nucleus and the midbrain reticular formation in the rat after 6-hydroxydopamine-induced lesions of ascending and descending catecholamine pathways.
    Howe PR; Head GA; Rogers PF
    J Hypertens; 1988 Jun; 6(6):443-50. PubMed ID: 3137256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of selective depletion of brain regional noradrenaline by systemic 6-hydroxydopamine in newborn rats.
    Liew MC; Laverty R
    Eur J Pharmacol; 1975 Aug; 33(1):165-72. PubMed ID: 1175683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
    Sawynok J; Reid A
    Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supersensitivity of the noradrenergic system in the spinal cord following intracisternal injection of 6-hydroxydopamine.
    Jones DJ; Alcantara OF; Ademe RM
    Neuropharmacology; 1984 Apr; 23(4):431-8. PubMed ID: 6145115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional depletion of central nervous system catecholamines: effects on blood pressure and drinking behavior.
    Gordon FJ; Brody MJ; Johnson AK
    Brain Res; 1985 Oct; 345(2):285-97. PubMed ID: 3930004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective depletion of spinal noradrenaline inhibits post-decapitation convulsions in rats.
    Bosland MC; Versteeg DH; de Jong W
    Experientia; 1980 Feb; 36(2):224. PubMed ID: 7371766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descending noradrenergic pathways involved in the A5 depressor response.
    Loewy AD; Marson L; Parkinson D; Perry MA; Sawyer WB
    Brain Res; 1986 Oct; 386(1-2):313-24. PubMed ID: 3096495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of chemical sympathectomy by 6-hydroxydopamine in newborn and adult rats.
    Finch L; Haeusler G; Thoenen H
    Br J Pharmacol; 1973 Feb; 47(2):249-60. PubMed ID: 4146573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine.
    Konkol RJ; Bendeich EG; Breese GR
    Brain Res; 1978 Jan; 140(1):125-35. PubMed ID: 626876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of spinal norepinephrine depletion on descending inhibition of the tail flick reflex from the locus coeruleus and lateral reticular nucleus in the rat.
    Janss AJ; Jones SL; Gebhart GF
    Brain Res; 1987 Jan; 400(1):40-52. PubMed ID: 3101973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional brain catecholamine levels and the development of hypertension in the spontaneously hypertensive rat: the effect of 6-hydroxydopamine.
    van den Buuse M; de Kloet ER; Versteeg DH; de Jong W
    Brain Res; 1984 Jun; 301(2):221-9. PubMed ID: 6428702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.